HealthBeacon is the World's Leading Digital Health Platform for Injectable Medications
Posted:
As many as 1-in-2 patients fail to adhere to their medication schedule. HealthBeacon's technologies integrate with patient support programs to significantly improve adherence for individuals with at home therapy regimens.
Currently more than 50 per cent of women are diagnosed with ovarian cancer at an advanced stage when fewer treatment options are available. A specialist medical tampon could be used to help diagnose ovarian cancer earlier, researchers believe.
Read more here.
A clinical trial into puberty blockers for children has been paused after the medicines regulator warned it should have a minimum age limit of 14 because of the “unquantified risk” of “long-term biological harms”.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us